Amphastar Pharmaceuticals Balance Sheet (2013-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Assets
Current Assets
Cash & Equivalents (Quarter)	106.61M	126.35M	172.63M	166.16M	157.24M	156.10M	176.62M	148.59M	266.78M	144.30M	201.15M	189.62M	192.12M	151.61M	182.78M	187.69M	216.26M	170.18M	170.94M	223.61M
Short-term Investments (Quarter)	0.20M	0.20M	0.20M	0.20M	2.20M	0.23M	16.28M	2.20M	4.26M	0.20M	0.23M	0.23M	0.20M	2.20M	0.20M	2.20M	0.20M	0.23M	0.20M	66.51M
Cash & Current Investments (Quarter)	106.81M	126.55M	172.83M	166.36M	159.44M	156.33M	192.89M	150.79M	271.04M	144.50M	201.38M	189.85M	192.32M	153.81M	182.98M	189.89M	216.47M	170.41M	171.14M	290.12M
Receivables - Net (Quarter)	78.09M	78.80M	73.17M	80.81M	77.10M	88.80M	100.64M	104.72M	118.99M	114.94M	138.11M	131.41M	139.63M	136.29M	144.64M	132.98M	146.81M	143.56M	147.85M	144.86M
Receivables - Other (Quarter)					0.20M		0.20M				0.30M	0.30M	0.40M			0.50M	0.50M		0.70M	0.90M
Receivables (Quarter)	78.09M	78.80M	73.17M	80.81M	77.30M	88.80M	100.84M	104.72M	118.99M	114.94M	138.41M	131.71M	140.03M	136.29M	144.64M	133.48M	147.31M	143.56M	147.85M	145.76M
Raw Materials (Quarter)	45.75M	41.85M	40.36M	43.90M	47.08M	47.61M	47.92M	44.63M	55.18M	50.08M	51.41M	56.44M	60.54M	81.51M	103.25M	106.55M	105.76M	106.83M	104.66M	105.50M
Work In Process (Quarter)	37.55M	33.30M	40.26M	40.09M	38.56M	37.09M	30.87M	31.77M	28.29M	30.82M	33.33M	38.55M	36.02M	32.81M	43.78M	43.59M	42.46M	40.44M	42.64M	44.30M
Finished Goods (Quarter)	16.93M	17.66M	14.53M	14.75M	17.61M	18.89M	24.86M	28.22M	26.50M	24.93M	30.75M	27.41M	33.76M	39.42M	38.45M	41.60M	37.71M	29.62M	22.89M	30.11M
Inventory (Quarter)	100.24M	92.81M	95.15M	98.73M	103.25M	103.58M	103.65M	104.62M	109.98M	105.83M	115.49M	122.41M	130.32M	153.74M	185.48M	191.73M	185.93M	176.89M	170.19M	179.91M
Current Deferred Tax Assets (Quarter)
Prepaid Assets (Quarter)	7.75M	7.27M	6.43M	5.90M	5.99M	7.56M	7.33M	5.87M	6.20M	9.06M	8.70M	7.95M	17.72M	18.21M	17.77M	20.33M	26.02M	13.15M	11.65M	11.00M
Current Assets (Quarter)	303.67M	318.12M	364.42M	377.14M	384.22M	378.32M	407.67M	384.55M	543.00M	489.60M	555.08M	482.64M	545.95M	534.07M	587.96M	580.83M	639.47M	636.02M	633.68M	630.95M
Non-Current Assets
Buildings (Quarter)
Construction in Progress (Quarter)
Land & Improvements (Quarter)
Property, Plant & Equipment (Net) (Quarter)	242.92M	244.24M	243.25M	237.56M	232.74M	264.57M	243.48M	278.53M	899.29M	282.75M	893.25M	288.00M	327.52M	297.35M	307.60M	354.73M	308.69M	353.72M	378.91M	389.13M
Long-Term Investments (Quarter)	4.19M	3.40M	3.50M	3.06M	2.69M	4.50M	4.90M	5.40M	0.97M	14.69M	7.80M	9.94M	9.40M	11.00M	5.91M	2.05M	13.30M	14.50M	14.40M	16.30M
Goodwill (Quarter)	3.39M	3.31M	3.26M	3.05M	2.89M	3.13M	3.17M	3.17M	32.32M	3.22M	3.15M	3.13M	3.26M	3.05M	3.16M	3.40M	3.40M	3.40M	3.33M	3.31M
Intangibles (Quarter)	29.23M	29.23M	29.20M	29.23M	29.23M	29.23M	29.23M	29.23M	29.20M	29.23M	29.23M	29.23M	29.23M	29.23M	29.23M	29.23M	29.23M	29.23M	29.23M	29.23M
Goodwill & Intangibles (Quarter)	39.19M	38.87M	38.44M	37.70M	37.04M	37.30M	37.18M	625.60M	619.35M	613.29M	607.06M	600.85M	594.80M	590.66M	584.53M	578.50M	572.24M	565.97M	559.62M	647.83M
Long-Term Deferred Tax (Quarter)	22.00M	22.40M	22.40M	22.40M	22.40M	38.53M	38.53M	40.87M	40.87M	53.25M	53.25M	53.25M	53.25M	71.12M	71.12M	71.12M	71.12M	42.46M	42.46M	42.46M
Other Non-Current Assets (Quarter)	11.61M	16.66M	16.30M	18.68M	20.55M	20.86M	18.54M	20.27M	25.30M	25.91M	23.37M	24.26M	23.66M	25.99M	22.99M	28.10M	29.87M	31.14M	33.48M	33.39M
Non-Current Assets (Quarter)	348.01M	353.41M	351.82M	346.57M	342.47M	363.67M	365.99M	993.71M	1,001.63M	1,023.31M	1,019.24M	1,008.88M	999.23M	1,043.40M	1,038.32M	1,034.50M	1,026.75M	993.28M	1,014.48M	1,112.82M
Assets (Quarter)	651.68M	671.53M	716.24M	723.72M	726.70M	741.99M	773.66M	1,378.27M	1,544.63M	1,512.91M	1,574.32M	1,491.52M	1,545.18M	1,577.47M	1,626.28M	1,615.33M	1,666.22M	1,629.30M	1,648.16M	1,743.77M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	21.66M	89.55M	95.81M	97.67M	19.96M	84.24M	21.98M	18.83M	222.72M	93.37M	116.70M	31.77M	34.09M	157.06M	52.81M	166.55M	40.54M	148.35M	35.50M	251.37M
Payables (Quarter)	21.66M	89.55M	95.81M	97.67M	19.96M	84.24M	21.98M	18.83M	222.72M	93.37M	116.70M	31.77M	34.09M	157.06M	52.81M	166.55M	40.54M	148.35M	35.50M	251.37M
Accumulated Expenses (Quarter)	67.25M	67.33M	71.97M	66.59M	75.83M	63.74M	66.91M	198.70M	190.75M	67.93M	80.16M	99.44M	119.18M	126.54M	123.13M	124.67M	150.30M	115.76M	117.19M	222.44M
Other Accumulated Expenses (Quarter)								0.20M
Short term Debt (Quarter)	2.26M	2.20M	2.16M	2.06M	1.68M	3.05M	2.17M	12.92M	0.43M	0.44M	0.43M	0.25M	0.25M	0.23M	0.22M	0.93M	0.92M	1.64M	1.67M	2.49M
Current Leases (Quarter)	2.86M	2.98M	3.28M	3.31M	3.18M	3.00M	2.99M	3.13M	3.72M	3.91M	3.94M	4.00M	4.21M	6.80M	7.75M	7.88M	7.83M	7.93M	9.71M	8.80M
Current Taxes (Quarter)	3.96M	9.08M	13.12M	0.60M	1.53M	4.57M	11.59M	17.70M	31.09M	1.61M	5.86M	1.51M	1.28M	9.66M	15.14M	1.05M	5.63M	0.24M	0.41M	0.55M
Current Deferred Revenue (Quarter)
Curent Deferred Tax Liability (Quarter)
Total Current Liabilities (Quarter)	97.99M	103.81M	114.36M	103.63M	102.19M	94.86M	105.64M	251.28M	257.96M	225.41M	255.17M	136.97M	159.01M	173.76M	199.05M	176.41M	205.23M	158.16M	164.48M	263.20M
Non-Current Liabilities
Non-Current Debt (Quarter)	75.55M	74.78M	74.35M	73.87M	74.01M	72.84M	72.87M	488.28M	638.21M	589.58M	594.01M	586.85M	596.45M	601.63M	603.86M	607.73M	608.58M	608.75M	609.80M	609.56M
Non-Current Deffered Revenue (Quarter)
Minority Interest (Quarter)
Non-Current Deferred Tax Liability (Quarter)	2.90M	0.53M	0.49M	0.36M	0.24M	0.14M	0.18M	0.20M	0.20M
Operating Leases (Quarter)	25.47M	24.70M	25.49M	24.68M	24.37M	23.69M	23.99M	24.41M	30.20M	29.72M	28.74M	29.48M	28.94M	41.88M	40.70M	38.96M	39.44M	37.68M	75.14M	67.47M
Other Non-Current Liabilities (Quarter)	14.88M	15.65M	15.49M	6.53M	14.19M	7.22M	15.18M	17.63M	7.22M	6.07M	17.98M	18.80M	27.04M	20.95M	24.42M	6.96M	6.96M	5.93M	5.93M	29.44M
Total Non-Current Liabilities (Quarter)	206.62M	210.35M	221.22M	217.88M	207.34M	206.10M	209.90M	771.40M	942.27M	867.42M	883.98M	759.37M	790.46M	824.23M	850.57M	850.89M	882.52M	834.57M	868.85M	946.16M
Total Liabilities (Quarter)	221.50M	226.01M	236.71M	224.41M	221.53M	213.33M	225.08M	789.03M	949.49M	873.49M	901.96M	778.18M	817.50M	845.17M	874.99M	857.85M	889.48M	840.49M	874.77M	975.61M
Shareholder's Equity
Total Debt (Quarter)	77.81M	76.98M	76.51M	75.93M	75.69M	75.89M	75.04M	501.20M	638.64M	590.01M	594.43M	587.10M	596.70M	601.86M	604.08M	608.65M	609.50M	610.39M	611.47M	612.05M
Common Equity (Quarter)	430.18M	445.52M	479.52M	499.31M	505.17M	528.66M	548.58M	589.24M	595.14M	639.42M	672.36M	713.35M	727.68M	732.30M	751.28M	757.48M	776.75M	788.80M	773.39M	768.16M
Liabilities and Shareholders Equity (Quarter)	651.68M	671.53M	716.24M	723.72M	726.70M	741.99M	773.66M	1,378.27M	1,544.63M	1,512.91M	1,574.32M	1,491.52M	1,545.18M	1,577.47M	1,626.28M	1,615.33M	1,666.22M	1,629.30M	1,648.16M	1,743.77M
Treasury Shares (Quarter)		-8.73M				-10.00M				-11.32M	-11.32M	-11.52M	-12.32M	-13.23M	-13.62M	-15.16M	-15.33M	-16.13M	-17.50M	-19.77M
Retained Earnings (Quarter)	412.92M	422.42M	-7.25M	221.94M	-9.93M	271.72M	456.62M	323.88M	477.88M	409.27M	452.44M	490.39M	530.82M	505.40M	594.07M	-5.36M	642.45M	666.88M	673.30M	703.65M

Research Tools

Datasets

Plans

Developers

Amphastar Pharmaceuticals AMPH Balance Sheet (2013-2026)

Research Tools

Datasets

Plans

Developers

Amphastar Pharmaceuticals AMPH Balance Sheet (2013-2026)

Create an account

Sign In

Reset Password